Cellebrite DI Ltd.
CLBT
$18.25
$0.975.61%
06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | ||
---|---|---|---|---|---|
Revenue | 95.71M | 93.01M | 84.18M | 76.68M | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | 95.71M | 93.01M | 84.18M | 76.68M | |
Cost of Revenue | 16.26M | 14.92M | 12.88M | 13.03M | |
Gross Profit | 79.45M | 78.10M | 71.30M | 63.65M | |
SG&A Expenses | 43.27M | 41.35M | 37.37M | 37.98M | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 83.23M | 78.01M | 70.70M | 72.06M | |
Operating Income | 12.49M | 15.00M | 13.48M | 4.62M | |
Income Before Tax | -22.02M | -12.35M | 6.85M | -31.43M | |
Income Tax Expenses | 1.80M | 2.30M | 349.00K | 920.00K | |
Earnings from Continuing Operations | -23.81M | -14.65M | 6.50M | -32.35M | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -23.81M | -14.65M | 6.50M | -32.35M | |
EBIT | 12.49M | 15.00M | 13.48M | 4.62M | |
EBITDA | 15.06M | 18.11M | 15.86M | 7.19M | |
EPS Basic | -0.12 | -0.08 | 0.03 | -0.17 | |
Normalized Basic EPS | -0.07 | -0.04 | -- | -0.10 | |
EPS Diluted | -0.12 | -0.08 | 0.03 | -0.18 | |
Normalized Diluted EPS | -0.07 | -0.04 | -- | -0.10 | |
Average Basic Shares Outstanding | 198.95M | 194.44M | 191.57M | 188.13M | |
Average Diluted Shares Outstanding | 198.95M | 194.44M | 204.39M | 188.13M | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |